Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Toxicology Letters|March 18, 2000
Arterial lesions induced by phosphodiesterase III (PDE III) inhibitors and DA(1) agonistsE C JosephHuman Toxicology|September 1, 1987
Keratoconjunctivitis sicca in the dog following 5-aminosalicylic acid administrationK C Barnett, E C JosephScandinavian Journal of Gastroenterology. Supplement|January 1, 1990
Mesalazine: an overview of key preclinical studiesK G Bilyard, E C Joseph, R MetcalfToxicologic Pathology|January 1, 1989
Coronary vascular lesions in dogs treated with phosphodiesterase III inhibitorsK R Isaacs, E C Joseph, G R BettonToxicologic Pathology|July 1, 1996
Characterization of coronary arterial lesions in the dog following administration of SK&F 95654, a phosphodiesterase III inhibitorE C Joseph, H B Jones, W D KernsJournal of Applied Toxicology : JAT|August 1, 1988
The evaluation of HBDH and LDH isoenzymes in cardiac cell necrosis of the ratR J Barrett, J H Harleman, E C JosephToxicologic Pathology|July 1, 1996
Mesenteric arteriopathy in the rat induced by phosphodiesterase III inhibitors: an investigation of morphological, ultrastructural, and hemodynamic changesE C Joseph, J A Rees, A D DayanArchives of Toxicology|May 1, 1986
Cardiotoxicity of a new inotrope/vasodilator drug (SK&F 94120) in the dogJ H Harleman, E C Joseph, R J Eden, et al.Toxicology and Applied Pharmacology|June 1, 1995
Chemical-induced vasculature injury. Summary of the symposium presented at the 32nd annual meeting of the Society of Toxicology, New Orleans, Louisiana, March 1993P J Boor, A I Gotlieb, E C Joseph, et al.Pageof 1